FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
Miso Robotics CEO Rich Hull discusses Flippy Fry Station, the future of AI-powered restaurant automation and how acquiring Zume's IP could reshape food robotics
After two years of AI-fueled spending, Wall Street is asking what's next. Gil Luria breaks down monetization, valuations, winners, losers, and AI's future.
PSYONIC CEO Dr. Aadeel Akhtar explains how the company's Ability Hand restores sensation for amputees while helping train smarter, more capable AI robots.